Open AccessCORR Insights®: Micrometastatic Drug Screening Platform Shows Heterogeneous Response to MAP Chemotherapy in Osteosarcoma Cell Lines
Author(s) -
Bruno Fuchs
Publication year - 2018
Publication title -
clinical orthopaedics and related research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.178
H-Index - 204
eISSN - 1528-1132
pISSN - 0009-921X
DOI - 10.1097/01.blo.0000540061.16243.f9
Subject(s) - osteosarcoma , medicine , sarcoma , cisplatin , metastasis , doxorubicin , cancer research , chemotherapy , oncology , in vivo , cancer , cell culture , methotrexate , pathology , biology , microbiology and biotechnology , genetics